These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 12769608)
1. Recent progress in the development of subtype selective nicotinic acetylcholine receptor ligands. Astles PC; Baker SR; Boot JR; Broad LM; Dell CP; Keenan M Curr Drug Targets CNS Neurol Disord; 2002 Aug; 1(4):337-48. PubMed ID: 12769608 [TBL] [Abstract][Full Text] [Related]
2. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization. Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626 [TBL] [Abstract][Full Text] [Related]
3. Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography. Sihver W; Gillberg PG; Nordberg A Neuroscience; 1998 Aug; 85(4):1121-33. PubMed ID: 9681951 [TBL] [Abstract][Full Text] [Related]
4. Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors. Wu J; Liu Q; Yu K; Hu J; Kuo YP; Segerberg M; St John PA; Lukas RJ J Physiol; 2006 Oct; 576(Pt 1):103-18. PubMed ID: 16825297 [TBL] [Abstract][Full Text] [Related]
5. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells. Riganti L; Matteoni C; Di Angelantonio S; Nistri A; Gaimarri A; Sparatore F; Canu-Boido C; Clementi F; Gotti C Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122 [TBL] [Abstract][Full Text] [Related]
15. Evidence for spare nicotinic acetylcholine receptors and a beta 4 subunit in bovine adrenal chromaffin cells: studies using bromoacetylcholine, epibatidine, cytisine and mAb35. Wenger BW; Bryant DL; Boyd RT; McKay DB J Pharmacol Exp Ther; 1997 May; 281(2):905-13. PubMed ID: 9152400 [TBL] [Abstract][Full Text] [Related]
16. Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors. Abreo MA; Lin NH; Garvey DS; Gunn DE; Hettinger AM; Wasicak JT; Pavlik PA; Martin YC; Donnelly-roberts DL; Anderson DJ; Sullivan JP; Williams M; Arneric SP; Holladay MW J Med Chem; 1996 Feb; 39(4):817-25. PubMed ID: 8632405 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes. Tasso B; Canu Boido C; Terranova E; Gotti C; Riganti L; Clementi F; Artali R; Bombieri G; Meneghetti F; Sparatore F J Med Chem; 2009 Jul; 52(14):4345-57. PubMed ID: 19548687 [TBL] [Abstract][Full Text] [Related]
18. UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes. Sharples CG; Kaiser S; Soliakov L; Marks MJ; Collins AC; Washburn M; Wright E; Spencer JA; Gallagher T; Whiteaker P; Wonnacott S J Neurosci; 2000 Apr; 20(8):2783-91. PubMed ID: 10751429 [TBL] [Abstract][Full Text] [Related]
19. Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains. Warpman U; Nordberg A Neuroreport; 1995 Nov; 6(17):2419-23. PubMed ID: 8747166 [TBL] [Abstract][Full Text] [Related]